seems like a godsend for them, fat burning, longer nails and longer hair, healthy glowing skin, im not sure why more women dont take it

During my cut on Reta I felt I was falling victim to being skinny fat so I decided to add tesavand ipa to re-comp and attempt to build some muscle while cutting down. I'd like to say it's been successful and i'm more confident looking in the mirror than when I started Tesa. The sleep and recovery has also been phenomenal. I love this pep for it's ability to help retain muscle mass in the cut and may even stay on after I get off Reta. Anyone else seen great results with these two compunds?

Why do girls make such a big fuss over petty things like periods? I think period pain is way too overrated. I've endured more pain in a single gym session than they endure in a week. What a bunch of pussies they are, demanding attention, care, and chocolate. I mean, WTF is wrong with you? You're not a kid anymore.

WSJ ran a piece on people who used GLP-1s for weight loss and later ended up in treatment for anorexia:

 https://www.wsj.com/health/wellness/glp1-anorexia-wegovy-mounjaro-1bf4035c

Worth reading alongside the primary literature from the past few months, because the reporting is no longer just anecdotal.

A JAMA Psychiatry survey published this summer (Levinson and colleagues) recruited 436 people with diagnosed eating disorders in 2025 and asked about GLP-1 use. Just over 32% reported having ever used one, and 22% reported current use. Broken out by diagnosis, a little over 50% of participants with binge eating disorder reported use, about 42% of those with atypical anorexia nervosa, roughly 30% of those with ARFID, over 25% of those with bulimia, and about 11% of those with anorexia nervosa. Roughly 10% obtained them through online providers prescribing compounded formulations. Over 10% reported misuse, defined as taking more or less than prescribed, using longer than prescribed, tampering with injection equipment, or sharing without a prescription.

The authors described the weight loss market as a rapidly evolving risk environment for this population.

Summary of the findings:

 https://www.medscape.com/viewarticle/many-eating-disorder-patients-using-glp-1s-2026a1000lym

In April, NEJM published a perspective by Amanda Banks raising the same concern from the prescribing side. She noted the share of GLP-1 prescriptions written for people who were not diabetic, obese, or overweight rose from 4.5% in 2018 to 17% in 2023, and argued for consensus recommendations to protect people with existing or emerging eating disorders. A 2023 FDA analysis found misuse reports for semaglutide were roughly four times higher than for other GLP-1 drugs.

NEJM perspective:

 https://www.nejm.org/doi/full/10.1056/NEJMp2600300

Clinician-side reporting describes the same pattern from treatment centers, including patients presenting at very low BMI while still dosing.

NPR, February 2026: https://www.npr.org/2026/02/04/nx-s1-5677633/glp-1-obesity-wegovy-zepbound-eating-disorders-anorexia-bulimia

Washington Post, May 2026: https://www.washingtonpost.com/health/2026/05/23/weight-loss-drugs-pose-dangers-people-with-eating-disorders/

MindSite News, May 2026: https://mindsitenews.org/2026/05/29/glp-1-access-a-problem-for-people-with-eating-disorders/

The mechanism cuts both ways, which is part of why this is hard to legislate around. A 2025 systematic review and meta-analysis found GLP-1 agonists reduced Binge Eating Scale scores by about 8 points, though the pooled sample was only 182 participants across five studies and heterogeneity was high. WSJ also covered that side on July 13 in a piece on clinicians treating certain eating disorders with these drugs. The same appetite and reward suppression that helps in binge-type presentations appears to reinforce restriction in people with a restrictive history. Same drug class, opposite clinical valence depending on phenotype.

Meta-analysis: https://link.springer.com/article/10.1007/s40519-025-01720-9

Penn Medicine's eating disorder program has said outright that no protocol exists to screen for eating disorders before prescribing GLP-1 receptor agonists. That gap widens with telehealth and disappears entirely outside a clinical relationship.

Penn Medicine:

 https://www.pennmedicine.org/physicians-hub/physician-article/implications-of-glp-1-medications-for-eating-disorder-care

ANAD clinical guidance:

 https://anad.org/learning-library/glp-1-medications-eating-disorders/

More stories at r/PeptideTides

I’m losing hair and the only option I’m seeing is Ru58841. I’m on minoxidil but it’s just not enough. I don’t find 5ar blockers like fin and Dut to be suitable for me as I am still fairly young and need DHT. I know Ru58841 has terrible side effect stories but I am still considering it, thoughts?

Seems nice, a good DHT boost, without affecting hormones at all, has anyone tried it?

Is this normal do I have to like get used to it or something? I mean killer workout yesterday and this morning but I feel headache slightly nauseous and lazy this afternoon. 37 M also running 500 test 4 iu HGH 2.5 mg Reta 25 mg Anavar split in 2 doses

Is room temp of for a few months? Or just freeze it?

My doctor said that HRT wouldn't be needed and id be fine.

Surgery is in September and I'm terrified. What do you all recommend to help healing and after effects? I've already made an appointment with another doc but was told there was likely nothing needed.